Non-drug evidence map · Oxygen, light, temperature and manual therapies

Intermittent hypoxia and hyperoxia

48 registered trials across 22 conditions, from ClinicalTrials.gov.

  1. Research Tracker
  2. Non-drug evidence map
  3. Intermittent hypoxia and hyperoxia

Controlled periods of breathing lower- or higher-oxygen air. This page lists the registered trials that test it, condition by condition, with each trial's status on ClinicalTrials.gov.

48registered trials
22conditions
27completed
2with results posted
12recruiting as of 2026-11-16
⚠️
Research information, not medical advice. These pages index what has been studied in registered trials. A trial existing, completing or posting results says nothing on its own about whether an approach works or is safe for you. Supplements and devices can interact with medicines. Discuss any change with your own clinician.

Trials by condition

Sorted by number of trials. Within a condition, trials with posted results come first, then completed, recruiting and active ones. The condition name opens its evidence-gap map.

ConditionTrialsCompletedResults postedRecruitingRandomisedLargest trial (participants)
Pulmonary Arterial Hypertension
Show trials
1414 00 1343
Multiple Sclerosis
Show trials
40 02 340
Obesity
Show trials
42 02 360
Ischemic Stroke
Show trials
32 00 31,230
Long COVID
Show trials
31 02 2120
Obstructive Sleep Apnea
Show trials
32 01 260
Type 2 Diabetes Mellitus
Show trials
31 12 3250
Parkinson Disease
Show trials
21 01 240
Type 1 Diabetes Mellitus
Show trials
22 10 230
Amyotrophic Lateral Sclerosis
Show trials
11 10 129
Asthma
Show trials
10 01 118
Bipolar Disorder
Show trials
11 00 1190
Cancer
Show trials
10 00 020
Chronic Obstructive Pulmonary Disease
Show trials
10 00 040
Colorectal Cancer
Show trials
10 00 020
Diabetic Neuropathy
Show trials
10 00 030
Heart Failure
Show trials
11 00 143
Lung Cancer
Show trials
10 00 160
Major Depressive Disorder
Show trials
10 00 10
Opioid Use Disorder
Show trials
10 01 1150
Osteoarthritis
Show trials
11 00 160
Peripheral Arterial Disease
Show trials
10 00 120

What these trials measure

Primary outcomes, grouped by keyword rules: Heart rate, blood pressure and autonomic (12), Physical function and exercise capacity (8), Inflammation and other biomarkers (7), Weight and metabolic markers (6), Cognition (5), Feasibility, adherence and safety (3), Breathing and lung function (3), Fatigue and energy (2), Mood, anxiety and wellbeing (2), Pain (2), Symptom severity and disease activity (1), Sleep (1).

Names used for this class in the registry

shamed hypoxia (fio2: 20.9), acute intermittent hypoxia, normobaric hypoxia (fio2 15%), normobaric hypoxia (fio2 15%) under sildenafil, hyperoxia, normobaric hyperoxia, normobaric hypoxia (nh), mild intermittent hypoxia, normobaric hypoxia, altitude-like hypoxia (12% o2), intermittent hypoxia intervention, vaporous hyperoxia therapy

Download all 48 trials (CSV) All non-drug classes

Related in Oxygen, light, temperature and manual therapies: Hyperbaric oxygen therapy · Light and laser therapy (photobiomodulation) · Heat, cold and water therapies · Acupuncture and related techniques · Massage, osteopathy and manual therapy · Shock-wave and vibration therapy · Compression and counterpulsation

Source: ClinicalTrials.gov, searched 2026-11-16. Classification rules and exclusions: how this map is built.